These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 23319530)

  • 41. A novel TMPRSS6 mutation that prevents protease auto-activation causes IRIDA.
    Altamura S; D'Alessio F; Selle B; Muckenthaler MU
    Biochem J; 2010 Nov; 431(3):363-71. PubMed ID: 20704562
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of TMPRSS6 and HFE variants in iron deficiency anemia in celiac disease.
    De Falco L; Tortora R; Imperatore N; Bruno M; Capasso M; Girelli D; Castagna A; Caporaso N; Iolascon A; Rispo A
    Am J Hematol; 2018 Mar; 93(3):383-393. PubMed ID: 29194702
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Iron refractory iron deficiency anemia.
    De Falco L; Sanchez M; Silvestri L; Kannengiesser C; Muckenthaler MU; Iolascon A; Gouya L; Camaschella C; Beaumont C
    Haematologica; 2013 Jun; 98(6):845-53. PubMed ID: 23729726
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Microcytic anaemia with low transferrin saturation, increased serum hepcidin and non-synonymous TMPRSS6 variants: not always iron-refractory iron deficiency anaemia.
    Donker AE; Brons PP; Swinkels DW
    Br J Haematol; 2015 Apr; 169(1):150-1. PubMed ID: 25312922
    [No Abstract]   [Full Text] [Related]  

  • 45. The role of TMPRSS6 gene polymorphism in iron resistance iron deficiency anaemia (IRIDA): a systematic review.
    Sharma A; Kumar A; Saha PK; Saha L
    Ann Hematol; 2024 Apr; 103(4):1085-1102. PubMed ID: 38072851
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Iron-refractory iron deficiency anemia].
    Kawabata H
    Rinsho Ketsueki; 2016 Feb; 57(2):104-9. PubMed ID: 26935626
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Association of
    Shinta D; ; Adhiyanto C; Htet MK; Fahmida U
    Nutrients; 2019 Apr; 11(4):. PubMed ID: 31010126
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Functional analysis of matriptase-2 mutations and domains: insights into the molecular basis of iron-refractory iron deficiency anemia.
    McDonald CJ; Ostini L; Bennett N; Subramaniam N; Hooper J; Velasco G; Wallace DF; Subramaniam VN
    Am J Physiol Cell Physiol; 2015 Apr; 308(7):C539-47. PubMed ID: 25588876
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Iron-Refractory Iron Deficiency Anemia with Novel TMPRSS6 Mutation.
    Huang DW; He GQ; Guo X; Wan Z; Gao J; Yang R
    Indian J Pediatr; 2024 Mar; 91(3):311. PubMed ID: 38052955
    [No Abstract]   [Full Text] [Related]  

  • 50. Molecular mechanisms of the defective hepcidin inhibition in TMPRSS6 mutations associated with iron-refractory iron deficiency anemia.
    Silvestri L; Guillem F; Pagani A; Nai A; Oudin C; Silva M; Toutain F; Kannengiesser C; Beaumont C; Camaschella C; Grandchamp B
    Blood; 2009 May; 113(22):5605-8. PubMed ID: 19357398
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Response to parenteral iron therapy distinguish unexplained refractory iron deficiency anemia from iron-refractory iron deficiency anemia.
    Akin M; Sarbay H; Guler S; Balci YI; Polat A
    Int J Lab Hematol; 2016 Apr; 38(2):167-71. PubMed ID: 26818204
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A new form of IRIDA due to combined heterozygous mutations of
    Pagani A; Colucci S; Bocciardi R; Bertamino M; Dufour C; Ravazzolo R; Silvestri L; Camaschella C
    Blood; 2017 Jun; 129(25):3392-3395. PubMed ID: 28476747
    [No Abstract]   [Full Text] [Related]  

  • 53. A novel tri-allelic mutation of TMPRSS6 in iron-refractory iron deficiency anaemia with response to glucocorticoid.
    Nie N; Shi J; Shao Y; Li X; Ge M; Huang J; Zhang J; Huang Z; Li D; Zheng Y
    Br J Haematol; 2014 Jul; 166(2):300-3. PubMed ID: 24661031
    [No Abstract]   [Full Text] [Related]  

  • 54. Natural history of recessive inheritance of DMT1 mutations.
    Iolascon A; Camaschella C; Pospisilova D; Piscopo C; Tchernia G; Beaumont C
    J Pediatr; 2008 Jan; 152(1):136-9. PubMed ID: 18154916
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A novel splice site mutation c.2278 (-1) G>C in the TMPRSS6 gene causes deletion of the substrate binding site of the serine protease resulting in refractory iron deficiency anaemia.
    Edison ES; Athiyarath R; Rajasekar T; Westerman M; Srivastava A; Chandy M
    Br J Haematol; 2009 Dec; 147(5):766-9. PubMed ID: 19747362
    [No Abstract]   [Full Text] [Related]  

  • 56. A novel splicing mutation of TMPRSS6 in a Chinese child with iron-refractory iron deficiency anaemia.
    Xiong Y; Wu Z; Yang W; Zhao X; Peng G; Tang K; Tian Z; Xing H; Rao Q; Wang M; Wang J; Zhang F
    Br J Haematol; 2015 Nov; 171(4):647-9. PubMed ID: 25873000
    [No Abstract]   [Full Text] [Related]  

  • 57. TMPRSS6 as a Therapeutic Target for Disorders of Erythropoiesis and Iron Homeostasis.
    Ganz T; Nemeth E; Rivella S; Goldberg P; Dibble AR; McCaleb ML; Guo S; Monia BP; Barrett TD
    Adv Ther; 2023 Apr; 40(4):1317-1333. PubMed ID: 36690839
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A novel mutation in the CUB sequence of matriptase-2 (TMPRSS6) is implicated in iron-resistant iron deficiency anaemia (IRIDA).
    Jaspers A; Caers J; Le Gac G; Ferec C; Beguin Y; Fillet G
    Br J Haematol; 2013 Feb; 160(4):564-5. PubMed ID: 23216605
    [No Abstract]   [Full Text] [Related]  

  • 59. Responsiveness to parenteral iron therapy in children with oral iron-refractory iron-deficiency anemia.
    Akin M; Atay E; Oztekin O; Karadeniz C; Karakus YT; Yilmaz B; Erdogan F
    Pediatr Hematol Oncol; 2014 Feb; 31(1):57-61. PubMed ID: 24087940
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Iron deficiency anaemia due to a matriptase-2 mutation].
    Cuijpers ML; Wiegerinck ET; Brouwer R; de Witte TJ; Swinkels DW
    Ned Tijdschr Geneeskd; 2010; 154():A1038. PubMed ID: 20719010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.